Encounter for antenatal screening for nuchal translucency
ICD-10 Z36.82 is a billable code used to indicate a diagnosis of encounter for antenatal screening for nuchal translucency.
Z36.82 is used to document encounters for antenatal screening specifically for nuchal translucency, a critical ultrasound measurement taken during the first trimester of pregnancy to assess the risk of chromosomal abnormalities such as Down syndrome. This screening is part of routine prenatal care and is essential for early detection, allowing for informed decision-making and potential further testing. Factors influencing health status include maternal age, family history, and previous pregnancy outcomes, which can affect the decision to undergo this screening. Social determinants such as access to healthcare, education level, and socioeconomic status can also impact a woman's ability to receive timely prenatal care. Preventive care through early screening can lead to better health outcomes for both the mother and the fetus, emphasizing the importance of regular contact with health services throughout pregnancy.
Documentation must include the reason for the screening, patient history, and any relevant risk factors. Clear notes on the ultrasound findings and follow-up plans are essential.
Routine prenatal visits where nuchal translucency screening is performed, including discussions about results and potential next steps.
Consideration of social determinants such as access to care, education, and support systems that may affect the patient's ability to attend screenings.
Documentation should focus on population health data, including screening rates and outcomes across different demographics.
Public health initiatives aimed at increasing awareness and access to prenatal screening services.
Tracking health disparities and ensuring equitable access to screening services for all populations.
Used during the encounter for nuchal translucency screening to document the procedure performed.
Documentation must include the indication for the ultrasound, findings, and any follow-up recommendations.
Primary care providers should ensure that the screening is part of routine prenatal care.
Accurate coding of Z36.82 is crucial for ensuring that patients receive appropriate preventive care and that healthcare providers are reimbursed for services rendered. It also helps track the effectiveness of screening programs and identify populations at risk for chromosomal abnormalities.
